​​​​​​​​Background

Non-melanoma skin cancers such as squamous cell carcinomas and basal cell carcinomas can be treated using a variety of methods, but surgery remains the principal form of treatment used. As incomplete tumour excision portends a potentially increased risk of tumour recurrence, one of the primary goals of our dermatologic surgeons is to ensure that they are adequately excised. 

 

Clinical Indicator

Rate of Incomplete Tumor Excision: Our rates of incomplete tumour excision for both Basal Cell Carcinomas and Squamous Cell Carcinomas show that we are consistently below the target of 4%. The experience of our surgeons, along with adherence to recommended excision margins, allows us to achieve favorable outcomes in our patients.

2023 QuartersIncomplete Tumor Excision Rate
Jan - Mar0.0%
Apr - Jun0.0%
Jul - Sep0.0%
Oct - Dec0.0%​



Note:  Leave the name of the tab "blank"if you do not wish to show this tab.